UroGen Pharma Ltd (URGN) earnings · rev $109.8M
These earnings events as JSON? API free 100/dayUroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
This URGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. Revenue was up 538.6% from 2023-03-31 to 2025-12-31. URGN currently screens at market cap $1.61B.
When the next URGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 538.6% from 2023-03-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full URGN research stays on the stock page; the tape stays on the quote page.
URGN earnings FAQ
What are URGN's latest revenue and net income?
Latest cached UroGen Pharma Ltd (URGN) revenue for Dec 31, 2025 was $109.8M. Net income was -$153.5M. Statements: https://lician.com/financials/urgn
What is URGN's latest basic EPS?
Latest cached UroGen Pharma Ltd (URGN) basic EPS for Dec 31, 2025 was -$3.19.
What period does the latest URGN earnings print cover?
The latest cached UroGen Pharma Ltd (URGN) earnings print covers Dec 31, 2025. The prior cached period on this page is Mar 31, 2023.
How did URGN revenue change from the prior cached period?
Cached UroGen Pharma Ltd (URGN) revenue was up 538.6% from $17.2M (Mar 31, 2023) to $109.8M (Dec 31, 2025). Statements: https://lician.com/financials/urgn
Where are URGN earnings listed?
Cached earnings facts for UroGen Pharma Ltd (URGN) are listed at https://lician.com/earnings/urgn. Statements: https://lician.com/financials/urgn
Not investment advice.